| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dace4112a41a87246ed37f5de36e7c3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
| filingDate |
1999-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4bc023ef4a12a52c3670dc43ff1759f |
| publicationDate |
2001-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6204360-B1 |
| titleOfInvention |
Retro-inverso thymosin alpha 1 hybrids |
| abstract |
Retro-inverso thymosin alpha 1 and its hybrids, native/retro-inverso thymosin alpha 1, possess the characteristics of greater stability and activity than their parent thymosin alpha 1. Such novel analogs and hybrids are useful for therapeutic purposes in viral, neoplastic and immunodeficiency diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008543733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004067884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005176636-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005250685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104558117-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010247482-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009171068-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104558117-A |
| priorityDate |
1999-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |